The drug "Trittiko" the instructions for use are defined as an antidepressant drug that is part of the triazolopyridine group and is actively used to treat various types of depressive disorders. This medicine has a pronounced
sedative effect, has anxiolytic activity and effectively eliminates the cause of mental disorder - a lack of serotonin. In addition, taking the antidepressant "Trittiko" (instructions for use explains this with its composition) speeds up the process of falling asleep and restores the structure of sleep, removes
feelings of anxiety and fear, headache, tachycardia and myalgia. Among other things, in a short time, this remedy eliminates affective tension, stabilizes the emotional state, reduces craving for alcohol and facilitates the rejection of benzodiazepines during remission.
The antidepressant drug
"Trittiko" is produced (the instructions for use confirm this) in the form of oval dragees of white or white-yellow color. The composition of each tablet as the main active ingredient includes trazodone hydrochloride in the amount of seventy-five or one hundred and fifty milligrams. Excipients are povidone, sucrose, magnesium stearate and carnauba wax.
To prescribe Trittiko tablets, the instruction recommends for the treatment of people suffering from anxiety-depressive states of endogenous nature, psychogenic depression or depressive states that developed against the background of organic diseases of the nervous system. In addition, this antidepressant helps with benzodiazepine addiction. Patients with anxiety conditions associated with a prolonged pain syndrome are also recommended to take the Trittiko medicine. Reviews also testify to the positive results of its use in alcohol depression, potency disorders and libido.
It is strictly forbidden to take this antidepressant if the patient has an increased sensitivity to trazodone hydrochloride or an allergic reaction to any other components presented in the composition. In addition, the list of direct contraindications includes pregnancy, age up to six years and the lactation period. With extreme caution, these tablets should be taken for people with arterial hypertension, AV blockade, or ventricular arrhythmia. Patients who have recently had a myocardial infarction are also advised to refrain from taking the antidepressant Trittiko. Instructions for use do not recommend taking it in the case of established liver or renal failure, a history of priapism. In addition, under the constant medical supervision of this drug should be used by persons under eighteen years of age.
Prolonged use of Trittiko tablets may cause drowsiness, fatigue, headaches, myalgia, orthostatic hypotension and arrhythmia. In addition, some people experience disorientation and discoordination, paresthesia, tremors, bradycardia, leukopenia and neutropenia due to the use of this antidepressant. In addition, there may be a decrease in appetite, dry mouth, nausea, eye irritation, priapism, urticaria, and hyperemia.